Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
2 Fte (5)
Lobbyists with EP accreditation
2
High-level Commission meetings
15
Lobbying Costs over the years
-
Info
Coalition for Epidemic Preparedness Innovations (CEPI)
EU Transparency Register
852523338633-03 First registered on 18 Jun 2020
Goals / Remit
Our vision: Creating a world in which epidemics and pandemics are no longer a threat to humanity
Our mission: to Accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in needsMain EU files targeted
• Regulation (EU) 2021/695 of the European Parliament and of the Council of 28 April 2021 establishing Horizon Europe – the Framework Programme for Research and Innovation, laying down its rules for participation and dissemination, and repealing Regulations (EU) No 1290/2013 and (EU) No 1291/2013
• Regulation (EU) 2021/522 of the European Parliament and of the Council of 24 March 2021 establishing a Programme for the Union’s action in the field of health (‘EU4Health Programme’) for the period 2021-2027, and repealing Regulation (EU) No 282/2014
• Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014
• Proposal for a Regulation of the European Parliament and of the Council laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
• Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC
• Council Recommendation on strengthened cooperation against vaccine-preventable diseases (2018/C 466/01)
• EU Global Health Strategy to improve global health security and deliver better health for allAddress
Head Office
Skøyen Atrium, Askekroken 11
Oslo 0277
NORWAYEU Office
Skøyen Atrium, Askekroken 11
Oslo 0277
NORWAYWebsite
-
People
Total lobbyists declared
5
Employment time Lobbyists 100% 1 25% 4 Lobbyists (Full time equivalent)
2
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
2 accreditations were / are live (in bold) for the selected state of 21 Nov 2024
Name Start date End Date Sally Suzanne Girgis 08 Nov 2024 07 Nov 2025 Willo BROCK 04 Oct 2024 03 Oct 2025 Complementary Information
n/a
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
n/a
Member organisations
Built on the principles of speed, scale and equitable access, CEPI is supporting the research and development of a diverse portfolio of vaccine candidates based on a range of vaccine approaches. The overview of such partnerships can be found in this link: https://cepi.net/research_dev/our-portfolio/
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
379,391,318€
Major funding types in closed year
Donations, Grants, Member's contributions, Other, Public funding
Funding types "other" information
CEPI is an organization founded by many sovereign countries - EU-members and non-EU-members alike - as well as private foundations, e.g. Wellcome Trust and the Gates Foundation, and other entities like the EU.
Major contributions in closed year
Type Name Amount Contribution Government of the United States of America 50,884,168€ Contribution Wellcome Trust 39,115,264€ Contribution Government of Japan 95,292,168€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
The mission of the Coalition for Epidemic Preparedness Innovations (CEPI) is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need. Since 2017, the joint partnership between CEPI and EC has generated many successes, especially reflected in the depth of collaboration of the CEPI- Health Emergency Preparedness and Response Authority of the European Commission (HERA) partnership from RVF work, to late stage CHIK development and human challenge models, which CEPI is keen to build on into 2024 and beyond. CEPI is also engaging with other parts of the EU, including across multiple Directorate-Generals, in order to promote synergies in investments to contribute to both European regional health security and global health security, develop common or more aligned approaches to vaccine libraries and enabling networks, and promote global equitable access in a globally coordinated response. CEPI’s work involves influencing the formulation of policies, legislative proposals, decisions and recommendations, through direct engagement with EC, participation in EC consultation or in studies commissioned by the EC, and supporting the implementation of relevant policies and programmes including via grants under Horizon 2020 and Horizon Europe. Activities to date have been conducted in line with the Letter of Intent Regarding Cooperation between CEPI and HERA. This includes a mandate for: regular, senior-level meetings to identify and discuss topics of mutual interest and review the progress of the cooperation; sharing of technical data and analysis, strategic insights and views on work plans; and exchange of information on related research, development, manufacturing and other priorities relevant for medical countermeasures in order to ensure cooperation on the overall priorities. Where relevant, HERA coordinates with other Commission services, acting as a contact point. The Letter of Intent is publicly available and can be found here: https://health.ec.europa.eu/document/download/291392aa-b829-4a8e-8bbc-6b56f7acc0b9_en?filename=hera_cepi_loi_en.pdf
Other activities
None declared
Meetings
Meetings
15 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 25 Jun 2024 Location online Subject Update on BioNTech partnerships following announcement at WHA DG Directorate-General for International Partnerships Attending - Koen Doens (Director-General)
-
Date 26 Jan 2024 Location online Subject End-to-end health security infrastructure in Rwanda DG Directorate-General for International Partnerships Attending - Koen Doens (Director-General)
-
Date 10 May 2023 Location Bruxelles Subject Meeting on preparedness for future cross border health emergencies Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Ines Prainsack (Cabinet member)
- Daphne von Buxhoeveden (Cabinet member)
-
Date 09 Jan 2023 Location Brussels Subject Meeting with CEO of the Coalition for Epidemic Preparedness Innovations (CEPI). DG Research and Innovation Attending - Signe Ratso (Acting Director-General)
-
Date 06 Dec 2022 Location online Subject DG SANTE – CEPI bilateral meeting DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 10 Nov 2021 Location Videoconference Subject Pandemic preparedness and the industrial dimension of HERA Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 10 Nov 2021 Location Brussels Subject Strengthening pandemic preparedness and response: a dialogue with CEPI CEO Richard Hatchett and Bill &Melinda Gates Foundation co-chair Melinda French Gates. DG Health and Food Safety Attending - Sandra Gallina (Director-General)
Other Lobbyists -
Date 04 Oct 2021 Location Brussels Subject COVID-19 Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 20 Jul 2021 Location Brussels Subject Vaccines and the way forward Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 18 Feb 2021 Location Virtual meeting Subject Discussion on the new coronavirus mutants, the HERA incubator, roll out of vaccines under COVAX and the vaccine sharing mechanism. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
-
Date 13 Jul 2020 Location Brussels (video conference) Subject COVID-19 Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 19 Jun 2020 Location Brussels (Video conference) Subject COVID-19 Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 10 Jun 2020 Location Brussels (video conference) Subject COVID-19 Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 02 Jun 2020 Location Brussels (video conference) Subject COVID-19 Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
Other Lobbyists -
Date 08 May 2020 Location Brussels (video-conference) Subject COVID-19 Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)